/Investor DB

Rock Springs Capital — 2021 Investments

6 investments dated 2021 · listed companies and verified rows first · show all

Disc Medicinediscmedicine.comin𝕏NASDAQ: IRONSep 2021 · $90M

Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need.

BiotechHealthtech

John Quisel(Chief Executive Officer)inJean Franchi(Chief Financial Officer)inJonathan Yu(Chief Operating Officer)inWill Savage(Chief Medical Officer)inPamela Stephenson(Chief Commercial Officer)inSteve Caffé(Chief Regulatory Officer)in

Co-investorsAccess BiotechnologyAtlas VentureBain Capital Life SciencesForesite CapitalFrazier Life SciencesHercules Capital, Inc.+8 more

Honorhonorcare.comin𝕏Oct 2021

Honor Technology develops technology platforms and operates brands that provide goods and services for aging adults, aiming to support independent living.

Digital HealthHealthtechLongevitySaaSSan Francisco, US

Cameron Ring(Founder)inMonica Doss(Co-Founder)Monica Lo(Founder)inSandy Jen(Founder)inSeth Sternberg(Founder)inLori Hogan.(Founder)

Co-investorsAndreessen HorowitzBaillie Gifford8VCAlumni VenturesBAM VenturesEnsemble Labs+7 more

Imperativeimperative.comin𝕏Jul 2021 · $260M

Chronus is a platform that connects employees for guided, AI-assisted conversations focused on career development, mentoring, community building, and change adoption in enterprise organizations.

AI & Machine LearningEnterprise SoftwareFuture of WorkHR TechSaaSNew York, US

Aaron Hurst(Founder)in

Co-investorsEmpire AngelsGaingelsSand Hill AngelsVoyager CapitalAlly Bridge GroupAmed Ventures+6 more

Theseustheseus.usinApr 2021

Theseus builds robotic situational awareness software using visual positioning for drones that operate in GPS-denied environments.

Advanced ManufacturingAI & Machine LearningDefense TechHardwareRoboticsSan Francisco, US

Ian Laffey(Chief Executive Officer)inSacha Lévy(Chief Technology Officer)inCarl Schoeller(Founder)Yasmin Acevedo(Recruiter)Luca Lery Moffat(COO)

Co-investorsY CombinatorFirst Round CapitalPioneerAntlerEndor CapitalForesite Capital+7 more

Theseus Pharmaceuticalstheseusrx.comApr 2021

BiotechCambridge, US

William C. Shakespeare(Director)in

BoardIain Dukes(Executive Officer, Director)inMichael Rome(Director)inCarl Gordon(Director)in

Co-investorsForesite CapitalLongitude CapitalNextech InvestNexTech VenturesOmega FundsOrbiMed+2 more

Verve Therapeuticsvervetx.comJan 2021

Cambridge, MA biotech developing single-course in vivo base editing medicines to permanently lower cardiovascular disease risk.

BiotechCambridge, US

Andrew Ashe(Executive Officer)Sekar Kathiresan(Founder)inAndrew Bellinger(Executive Officer)Kiran Musunuru(Founder)

BoardJohn Evans(Director)Anthony Philippakis(Director)in

Co-investorsARCH Venture PartnersF-Prime CapitalGV (Google Ventures)RA CapitalvenBio PartnersWellington Management+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.